title: Fetal programming and environmental exposures: implications for prenatal care and preterm birth.
abstract: Sponsored by the New York Academy of Sciences and Cincinnati Children's Hospital Medical Center, with support from the National Institute of Environmental Health Sciences (NIEHS), the National Institute on Drug Abuse (NIDA), and Life Technologies, "Fetal Programming and Environmental Exposures: Implications for Prenatal Care and Preterm Birth" was held on June 11-12, 2012 at the New York Academy of Sciences in New York City. The meeting, comprising individual talks and panel discussions, highlighted basic, clinical, and translational research approaches, and highlighted the need for specialized testing of drugs, consumer products, and industrial chemicals, with a view to the unique impacts these can have during gestation. Speakers went on to discuss many other factors that affect prenatal development, from genetics to parental diet, revealing the extraordinary sensitivity of the developing fetus.
authors.affiliation: National Institute of Environmental Health Sciences, Research Triangle Park, North Carolina 27709, USA. schugt@niehs.nih.gov
authors.forename: Thaddeus T
authors.initials: TT
authors.lastname: Schug
authors.forename: Adrian
authors.initials: A
authors.lastname: Erlebacher
authors.forename: Sarah
authors.initials: S
authors.lastname: Leibowitz
authors.forename: Liang
authors.initials: L
authors.lastname: Ma
authors.forename: Louis J
authors.initials: LJ
authors.lastname: Muglia
authors.forename: Oliver J
authors.initials: OJ
authors.lastname: Rando
authors.forename: John M
authors.initials: JM
authors.lastname: Rogers
authors.forename: Roberto
authors.initials: R
authors.lastname: Romero
authors.forename: Frederick S
authors.initials: FS
authors.lastname: vom Saal
authors.forename: David L
authors.initials: DL
authors.lastname: Wise
mesh_terms: D064420:Drug-Related Side Effects and Adverse Reactions; D052244:Endocrine Disruptors / Q000009:adverse effects; D004781:Environmental Exposure / Q000009:adverse effects*; D005260:Female; D047109:Fetal Development / Q000235:genetics; D006801:Humans; D011247:Pregnancy; D047928:Premature Birth; D011295:Prenatal Care; D057170:Translational Research, Biomedical
chemical_list: D052244:Endocrine Disruptors